4Scime A, Li L, Ciavarra G, et al. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity[J]. J Cell Physiol, 2008, 214(3) : 568 -581.
3Kokkola R, Li J, Sundberg E, et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracel- lular high mobility group box chromosomal protein 1 activity[J]. Arthritis Rheum, 2003, 48 (7): 2052-2058. DOh 10.1002/art. 11161.
4Park JS, Svetkauskaite D, He QB, et al. Involvement of' toll-like receptors2 and 4 in celluzu" activation by high mobility group boxl protein[J]. J Biol Chem, 2004, 279(9): 7370-7377. DOI: 10.1074/jbc.M306793200.
5Pullerits R, Jonsson l-M, Verdrengh M, et al. High mobility group box chromosomal protein 1, a DNA binding cytnkine, in- duces arthritis[J]. Arthrilis Rheum, 2003, 48(6): 1693 1700. DOI: 10.1002/art.11028.
6Scime A, Li L, Civaarra G, et al. Cylin DI/CDK4 can interact with E2F4/DPI and disrupt its DNA-binding capacity[J]. Cell Physiol, 2008, 214(3): 568-581. DOI: 10.1002/jep.21243.
7Van der Pouw-Kraan TC, Van Gaalen FA, Kasperkovitz PV, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues[J]. Arthritis Rheum, 2003, 48 (8) : 2132- 2145. DOI: 10.1002/art. 11096.
8Kasperkovitz PV, Verbeet NL, Smeets TJ, et al. Activation of the STAT! Pathway in rheumatoid arthritis[J]. Ann Rheum Dis, 2004, 63(3): 233-239. DOI: 10.1136/ard.2003.013276.
9Kim HY, Park SY, Lee SW, et al. Inhibition of HMGBI-in- duced angiogenesis by cilostazol via SIRTI activation in synovial fibroblasts from rheumatoid arthritis[J]. PLoS ONE, 2014, 9(8): e104743. DOI: 10.1371/journal.pone.0104743.eCollection 2014.
10Andersson U, Tracey KJ. HMGB1 as a mediator of necrosis induced inflammation and therapeutic target in arthritis [J]. Rheum Dis Clin North Am, 2004, 30(3): 627-637. DOI: http: //dx.doi.org/10. I 016/j.rdc.2004.04.007.
